Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line

Han Byoul Cho, Eun Suk Kang, Soon Won Hong, Youn Jin Oh, Sun Mi Choi, Sang Wun Kim, Sung Hoon Kim, YoungTae Kim, Kyoung Sun Lee, Yang Kyu Choi, Jae-Hoon Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The existence of several model systems with which to investigate a particular disease is advantageous for researchers. This is especially true for ovarian cancer, which, due to its complex and heterogeneous nature, inherently requires a large number of model systems. Here, we report a new ovarian serous adenocarcinoma cell line, designated YDOV-157, and characterized via post genomics and post proteomics. In this study, primary culture of tumor cells from ascites was performed and the cells were immortalized up to at least 60 passages in vitro. We studied the morphologies, cell proliferation, BRCA1/2 mutations, tumorigenesis capacity, and chemosensitivity of YDOV-157. Using a cDNA microarray, differentially expressed genes were identified and some of them were validated. Using proteomic analysis, we identified proteins that were differentially expressed in YDOV-157. The newly derived cell line, designated YDOV-157, grew as a monolayer and the doubling time was 102 h. When transplanted into nude mice, it initiated the formation of tumor masses with microscopic findings identical to those of the primary tumor. Chemosensitivity test showed that paclitaxel induced the highest chemosensitivity index. In microarray analysis, 2,520 probes were differently expressed, compared to human ovarian surface epithelial cells (HOSEs). In SYBR Green real-time PCR, the expression of E2F2 (P = 0.040) and CRABP2 genes (P = 0.030) was significantly higher in the ovarian cancer cell lines than in HOSEs. Furthermore, proteomic analysis showed that expression of 28 spots was significantly altered between YDOV-157 and HOSE. In conclusion, the newly derived YDOV-157 cell line may be an important research resource for studying cancer cell biology and should also be very useful for developing new strategies that inhibit cancer cell growth and progression.

Original languageEnglish
Pages (from-to)189-201
Number of pages13
JournalMolecular and Cellular Biochemistry
Volume319
Issue number1-2
DOIs
Publication statusPublished - 2008 Dec 1

Fingerprint

Proteomics
Cells
Cell Line
Tumors
Epithelial Cells
Neoplasms
Microarrays
Ovarian Neoplasms
Genes
Cytology
Primary Cell Culture
Cell proliferation
Cell growth
Microarray Analysis
Genomics
Paclitaxel
Oligonucleotide Array Sequence Analysis
Cell culture
Ascites
Nude Mice

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Cho, Han Byoul ; Kang, Eun Suk ; Hong, Soon Won ; Oh, Youn Jin ; Choi, Sun Mi ; Kim, Sang Wun ; Kim, Sung Hoon ; Kim, YoungTae ; Lee, Kyoung Sun ; Choi, Yang Kyu ; Kim, Jae-Hoon. / Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line. In: Molecular and Cellular Biochemistry. 2008 ; Vol. 319, No. 1-2. pp. 189-201.
@article{addc522b92e34e238a8a7c17e9b06814,
title = "Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line",
abstract = "The existence of several model systems with which to investigate a particular disease is advantageous for researchers. This is especially true for ovarian cancer, which, due to its complex and heterogeneous nature, inherently requires a large number of model systems. Here, we report a new ovarian serous adenocarcinoma cell line, designated YDOV-157, and characterized via post genomics and post proteomics. In this study, primary culture of tumor cells from ascites was performed and the cells were immortalized up to at least 60 passages in vitro. We studied the morphologies, cell proliferation, BRCA1/2 mutations, tumorigenesis capacity, and chemosensitivity of YDOV-157. Using a cDNA microarray, differentially expressed genes were identified and some of them were validated. Using proteomic analysis, we identified proteins that were differentially expressed in YDOV-157. The newly derived cell line, designated YDOV-157, grew as a monolayer and the doubling time was 102 h. When transplanted into nude mice, it initiated the formation of tumor masses with microscopic findings identical to those of the primary tumor. Chemosensitivity test showed that paclitaxel induced the highest chemosensitivity index. In microarray analysis, 2,520 probes were differently expressed, compared to human ovarian surface epithelial cells (HOSEs). In SYBR Green real-time PCR, the expression of E2F2 (P = 0.040) and CRABP2 genes (P = 0.030) was significantly higher in the ovarian cancer cell lines than in HOSEs. Furthermore, proteomic analysis showed that expression of 28 spots was significantly altered between YDOV-157 and HOSE. In conclusion, the newly derived YDOV-157 cell line may be an important research resource for studying cancer cell biology and should also be very useful for developing new strategies that inhibit cancer cell growth and progression.",
author = "Cho, {Han Byoul} and Kang, {Eun Suk} and Hong, {Soon Won} and Oh, {Youn Jin} and Choi, {Sun Mi} and Kim, {Sang Wun} and Kim, {Sung Hoon} and YoungTae Kim and Lee, {Kyoung Sun} and Choi, {Yang Kyu} and Jae-Hoon Kim",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/s11010-008-9892-4",
language = "English",
volume = "319",
pages = "189--201",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line. / Cho, Han Byoul; Kang, Eun Suk; Hong, Soon Won; Oh, Youn Jin; Choi, Sun Mi; Kim, Sang Wun; Kim, Sung Hoon; Kim, YoungTae; Lee, Kyoung Sun; Choi, Yang Kyu; Kim, Jae-Hoon.

In: Molecular and Cellular Biochemistry, Vol. 319, No. 1-2, 01.12.2008, p. 189-201.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line

AU - Cho, Han Byoul

AU - Kang, Eun Suk

AU - Hong, Soon Won

AU - Oh, Youn Jin

AU - Choi, Sun Mi

AU - Kim, Sang Wun

AU - Kim, Sung Hoon

AU - Kim, YoungTae

AU - Lee, Kyoung Sun

AU - Choi, Yang Kyu

AU - Kim, Jae-Hoon

PY - 2008/12/1

Y1 - 2008/12/1

N2 - The existence of several model systems with which to investigate a particular disease is advantageous for researchers. This is especially true for ovarian cancer, which, due to its complex and heterogeneous nature, inherently requires a large number of model systems. Here, we report a new ovarian serous adenocarcinoma cell line, designated YDOV-157, and characterized via post genomics and post proteomics. In this study, primary culture of tumor cells from ascites was performed and the cells were immortalized up to at least 60 passages in vitro. We studied the morphologies, cell proliferation, BRCA1/2 mutations, tumorigenesis capacity, and chemosensitivity of YDOV-157. Using a cDNA microarray, differentially expressed genes were identified and some of them were validated. Using proteomic analysis, we identified proteins that were differentially expressed in YDOV-157. The newly derived cell line, designated YDOV-157, grew as a monolayer and the doubling time was 102 h. When transplanted into nude mice, it initiated the formation of tumor masses with microscopic findings identical to those of the primary tumor. Chemosensitivity test showed that paclitaxel induced the highest chemosensitivity index. In microarray analysis, 2,520 probes were differently expressed, compared to human ovarian surface epithelial cells (HOSEs). In SYBR Green real-time PCR, the expression of E2F2 (P = 0.040) and CRABP2 genes (P = 0.030) was significantly higher in the ovarian cancer cell lines than in HOSEs. Furthermore, proteomic analysis showed that expression of 28 spots was significantly altered between YDOV-157 and HOSE. In conclusion, the newly derived YDOV-157 cell line may be an important research resource for studying cancer cell biology and should also be very useful for developing new strategies that inhibit cancer cell growth and progression.

AB - The existence of several model systems with which to investigate a particular disease is advantageous for researchers. This is especially true for ovarian cancer, which, due to its complex and heterogeneous nature, inherently requires a large number of model systems. Here, we report a new ovarian serous adenocarcinoma cell line, designated YDOV-157, and characterized via post genomics and post proteomics. In this study, primary culture of tumor cells from ascites was performed and the cells were immortalized up to at least 60 passages in vitro. We studied the morphologies, cell proliferation, BRCA1/2 mutations, tumorigenesis capacity, and chemosensitivity of YDOV-157. Using a cDNA microarray, differentially expressed genes were identified and some of them were validated. Using proteomic analysis, we identified proteins that were differentially expressed in YDOV-157. The newly derived cell line, designated YDOV-157, grew as a monolayer and the doubling time was 102 h. When transplanted into nude mice, it initiated the formation of tumor masses with microscopic findings identical to those of the primary tumor. Chemosensitivity test showed that paclitaxel induced the highest chemosensitivity index. In microarray analysis, 2,520 probes were differently expressed, compared to human ovarian surface epithelial cells (HOSEs). In SYBR Green real-time PCR, the expression of E2F2 (P = 0.040) and CRABP2 genes (P = 0.030) was significantly higher in the ovarian cancer cell lines than in HOSEs. Furthermore, proteomic analysis showed that expression of 28 spots was significantly altered between YDOV-157 and HOSE. In conclusion, the newly derived YDOV-157 cell line may be an important research resource for studying cancer cell biology and should also be very useful for developing new strategies that inhibit cancer cell growth and progression.

UR - http://www.scopus.com/inward/record.url?scp=55649089420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55649089420&partnerID=8YFLogxK

U2 - 10.1007/s11010-008-9892-4

DO - 10.1007/s11010-008-9892-4

M3 - Article

VL - 319

SP - 189

EP - 201

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -